Your request to link to rcsb for Cytochrome P450 2C9

---

• 1OG2: structure of human cytochrome p450 cyp2c9 (10.1038/NATURE01862 )
• 1OG5: structure of human cytochrome p450 cyp2c9 (10.1038/NATURE01862 )
• 1R9O: crystal structure of p4502c9 with flurbiprofen bound (10.1074/JBC.M405427200 )
• 4GQS: structure of human microsomal cytochrome p450 (cyp) 2c19 (10.1074/JBC.M112.424895 )
• 4NZ2: crystal structure of cyp2c9 in complex with an inhibitor (10.1016/J.DRUDIS.2014.03.012 )
• 5A5I: cytochrome 2c9 p450 inhibitor complex (10.1039/C6MD00011H )
• 5A5J: cytochrome 2c9 p450 inhibitor complex
• 5K7K: design and optimization of biaryl ether aryl sulfonamides as selective inhibitors of nav1.7: discovery of clinical candidate pf-05089771 (10.1021/ACS.JMEDCHEM.7B00598 )
• 5W0C: cytochrome p450 (cyp) 2c9 tca007 inhibitor complex (10.1002/ANIE.201707324 )
• 5X23: crystal structure of cyp2c9 genetic variant a477t (*30) in complex with multiple losartan molecules (10.1021/ACS.BIOCHEM.7B00795 )
• 5X24: crystal structure of cyp2c9 genetic variant i359l (*3) in complex with multiple losartan molecules (10.1021/ACS.BIOCHEM.7B00795 )
• 5XXI: crystal structure of cyp2c9 in complex with multiple losartan molecules (10.1021/ACS.BIOCHEM.7B00795 )
• 6VLT: crystal structure of human p450 2c9*2 genetic variant in complex with losartan (10.1124/MOLPHARM.120.000042 )
• 7RL2: crystal structure of the human cytochrome p450 2c9*8 (cyp2c9*8) genetic variant in complex with the drug losartan (10.3390/IJMS221910206 )